{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:07:14Z","timestamp":1785550034848,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijgc.2025.101965","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:05:24Z","timestamp":1749157524000},"page":"101965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Laparoscopic tumor load as an independent prognostic marker in advanced ovarian cancer: a 3-year cohort study"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-8686","authenticated-orcid":false,"given":"Marco","family":"D\u2019Indinosante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2162-9863","authenticated-orcid":false,"given":"Giacomo","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-1195","authenticated-orcid":false,"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Diella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-8133","authenticated-orcid":false,"given":"Riccardo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7004-2462","authenticated-orcid":false,"given":"Alice Zampolini","family":"Faustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Querleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-335X","authenticated-orcid":false,"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijgc.2025.101965_bib2","first-page":"101","volume":"42","author":"Griffiths","year":"1975"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101965_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101965_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ijgc-2020-001505","article-title":"Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer","volume":"31","author":"Greer","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101965_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2017.02.023","article-title":"Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?","volume":"145","author":"Sioulas","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101965_bib7","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101965_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.101965_bib9","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1245\/s10434-014-3783-6","article-title":"Influence of intraperitoneal dissemination assessed by laparoscopy on prognosis of advanced ovarian cancer: an exploratory analysis of a single-institution experience","volume":"21","author":"Vizzielli","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101965_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ijgc-2023-005158","article-title":"Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection","volume":"34","author":"Sanson","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101965_bib11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamaoncol.2023.2283","article-title":"Treatment with niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: a phase 3 randomized clinical trial","volume":"9","author":"Li","year":"2023","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.101965_bib12","first-page":"2315","article-title":"Initial incomplete surgery modifies prognosis in advanced ovarian cancer regardless of subsequent management","volume":"35","author":"Bacalbasa","year":"2015","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2013.08.005","article-title":"Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience","volume":"131","author":"Fagotti","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101965_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.101965_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.101965_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/ijgc-2021-003116","article-title":"BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score","volume":"32","author":"Ergasti","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2017.05.023","article-title":"Subtypes of Stage IV ovarian cancer; response to treatment and patterns of disease recurrence","volume":"146","author":"Jamieson","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2016.05.021","article-title":"The revised 2014 FIGO staging system for epithelial ovarian cancer: is a subclassification into FIGO stage IVA and IVB justified?","volume":"142","author":"Ataseven","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jso.25941","article-title":"Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer","volume":"122","author":"Feng","year":"2020","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101965_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/IGC.0000000000001186","article-title":"The FIGO Stage IVA versus IVB of ovarian cancer: prognostic value and predictive value for neoadjuvant chemotherapy","volume":"28","author":"Tajik","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101965_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/0284186X.2017.1400691","article-title":"Lymph node metastases as only qualifier for Stage IV serous ovarian cancer confers longer survival than other sites of distant disease \u2013 a Swedish gynecologic cancer group (SweGCG) study","volume":"57","author":"Hjerpe","year":"2018","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.101965_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2019.02.018","article-title":"Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?","volume":"153","author":"Mert","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.101965_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2020.06.495","article-title":"A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer","volume":"158","author":"Angeles","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.101965_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101965_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000539295","article-title":"Related clinical factors of platinum-based chemotherapy resistance in patients with epithelial ovarian cancer","volume":"89","author":"Xiong","year":"2024","journal-title":"Gynecol Obstet Investig"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101965_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108523","article-title":"The paradigm shift in advanced ovarian cancer: outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis","volume":"50","author":"Bianchi","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101965_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(14)71135-0","article-title":"Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.ijgc.2025.101965_bib28","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:42:30Z","timestamp":1785548550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25010850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1048891X25010850"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101965","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laparoscopic tumor load as an independent prognostic marker in advanced ovarian cancer: a 3-year cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101965"}}